CPC C12N 15/1137 (2013.01) [A61K 31/167 (2013.01); A61K 31/19 (2013.01); A61K 31/22 (2013.01); A61K 31/222 (2013.01); A61K 31/235 (2013.01); A61K 31/365 (2013.01); A61K 31/496 (2013.01); A61K 31/538 (2013.01); A61K 31/551 (2013.01); A61K 31/713 (2013.01); A61K 38/15 (2013.01); A61K 45/06 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01)] | 7 Claims |
1. A drug delivery device comprising:
a) a first container comprising a SMYD2 inhibitor that reactivates latent immunodeficiency virus transcription; and
b) a second container comprising an agent that inhibits an immunodeficiency virus function selected from viral replication, viral protease activity, viral reverse transcriptase activity, viral entry into a cell, viral integrase activity, viral Rev activity, viral Tat activity, viral Nef activity, viral Vpr activity, viral Vpu activity, and viral Vif activity.
|